Last reviewed · How we verify
Pentosan polysulfate sodium 100 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Pentosan polysulfate sodium 100 mg (Pentosan polysulfate sodium 100 mg) — Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pentosan polysulfate sodium 100 mg TARGET | Pentosan polysulfate sodium 100 mg | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pentosan polysulfate sodium 100 mg CI watch — RSS
- Pentosan polysulfate sodium 100 mg CI watch — Atom
- Pentosan polysulfate sodium 100 mg CI watch — JSON
- Pentosan polysulfate sodium 100 mg alone — RSS
Cite this brief
Drug Landscape (2026). Pentosan polysulfate sodium 100 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/pentosan-polysulfate-sodium-100-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab